Uterine cancer incidence and mortality rates are projected to increase significantly through 2050, according to a study ...

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

In this open-label, single-arm phase 2 study, women (aged ≥18 years) with recurrent low-grade serous ovarian or peritoneal carcinoma were given selumetinib (50 mg twice daily, orally) until ...

Uterine cancer rates in the United States are expected to climb significantly over the next 25 years, with Black women ...

Uterine cancer incidence is projected to increase an average of 40.8% between 2018 and 2050, with a bulk of the increase expected to occur among Black women. Mortality rates may almost double, ...